Ekpereonne Esu

Ekpereonne Esu

Auto-generated profile, based on publicly available information

Ekpereonne Esu

University of Calabar

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
EEEkpereonne Esu
Ekpereonne Esu
ALAudrey Lenhart
Audrey Lenhart
LSLucy Smith
Lucy Smith
OHOlaf Horstick
Olaf Horstick

3 February 2016 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
COChioma Oringanje
Chioma Oringanje
MMMartin M Meremikwu
Martin M Meremikwu
HEHokehe Eko
Hokehe Eko
EEEkpereonne Esu
Ekpereonne Esu
AMAnne Meremikwu
Anne Meremikwu
JEJohn E Ehiri
John E Ehiri

15 February 2012 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MMMartin Meremikwu
Martin Meremikwu
SDSarah Donegan
Sarah Donegan
DSDavid Sinclair
David Sinclair
EEEkpereonne Esu
Ekpereonne Esu
COChioma Oringanje
Chioma Oringanje

16 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AOAngela Oyo-Ita
Angela Oyo-Ita
XBXavier Bosch-Capblanch
Xavier Bosch-Capblanch
ARAmanda Ross
Amanda Ross
AOAfiong Oku
Afiong Oku
EEEkpereonne Esu
Ekpereonne Esu
MMMartin Meremikwu
Martin Meremikwu
Background: Vaccination coverage levels fall short of the Global Vaccine and Action Plan 90% target in low- and middle- income countries (LMICs). Having identified traditional and religious leaders (TRLs) as potential public health change agents, this study aimed at assessing the effect of training them to support routine immunisation for the purpose of improving uptake of childhood vaccines in Cross River State, Nigeria. Methods: A cluster-randomised controlled study was conducted between 2016 and 2019. Of the 18 Local Government Areas (LGA) in Cross River State, eight (four urban and four rural LGAs) were randomized into the intervention and control study arms. A multi-component intervention involving the training of traditional and religious leaders was implemented in the four intervention LGAs. Baseline, midline and endline surveys collected information on children aged 0–23 months. The effect of the intervention on outcomes including the proportion fully up-to-date with vaccination, timely vaccination for pentavalent and measles vaccines, and pentavalent 1–3 dropout rates were estimated using logistic regression models using random effects to account for the clustered data. Results: A total of 2598 children at baseline, 2570 at midline, and 2550 at endline were included. The intervention was effective in increasing the proportion with at least one vaccine (OR 12.13 95% CI 6.03–24.41p<0.001). However, there was no evidence of an impact on the proportion of children up-to-date with vaccination (p = 0.69). It was effective in improving timeliness of Pentavalent 3 (OR 1.55; 95% CI: 1.14, 2.12; p = 0.005) and Measles (OR 2.81; 96% CI: 1.93–4.1; p<0.001) vaccination. The odds of completing Pentavalent vaccination increased (OR = 1.66 95% CI: 1.08,2.55). Conclusion: Informal training to enhance the traditional and religious leaders’ knowledge of vaccination and their leadership role can empower them to be good influencers for childhood vaccination. They constitute untapped resources in the community to boost routine immunisation. Pan African Clinical Trial Registry (PACTR) PACTR202008784222254.

2 April 2024 in Environment International
Verified
Journal Article
Open access
XBXavier Bosch-Capblanch
Xavier Bosch-Capblanch
EEEkpereonne Esu
Ekpereonne Esu
COChioma Moses Oringanje
Chioma Moses Oringanje
SDStefan Dongus
Stefan Dongus
HJHamed Jalilian
Hamed Jalilian
Martin RöösliMartin Röösli
Martin Röösli
The technological applications of radiofrequency electromagnetic fields (RF-EMF) have been steadily increasing since the 1950s exposing large proportions of the population. The World Health Organization (WHO) is assessing the potential health effects of exposure to RF-EMF. To systematically assess the effects of exposure to RF-EMF on self-reported non-specific symptoms in human subjects and to assess the accuracy of perceptions of presence or absence of RF-EMF exposure. Eligibility criteria: experimental studies carried out in the general population and in individuals with idiopathic environmental intolerance attributed to EMF (IEI-EMF), in any language. Medline, Web of Science, PsycInfo, Cochrane Library, Epistemonikos, Embase and EMF portal, searched till April 2022. Risk of Bias (ROB): we used the RoB tool developed by OHAT adapted to the topic of this review. we synthesized studies using random effects meta-analysis and sensitivity analyses, where appropriate. Included studies: 41 studies were included, mostly cross over trials and from Europe, with a total of 2,874 participants. considering the primary outcomes, we carried out meta-analyses of 10 exposure-outcomes pairs. All evidence suggested no or small non-significant effects of exposure on symptoms with high (three comparisons), moderate (four comparisons), low (one comparison) and very low (two comparisons) certainty of evidence. The effects (standard mean difference, where positive values indicate presence of symptom being exposed) in the general population for head exposure were (95% confidence intervals) 0.08 (-0.07 to 0.22) for headache, -0.01 (-0.22 to 0.20) for sleeping disturbances and 0.13 (-0.51 to 0.76) for composite symptoms; and for whole-body exposure: 0.09 (-0.35 to 0.54), 0.00 (-0.15 to 0.15) for sleeping disturbances and -0.05 (-0.17 to 0.07) for composite symptoms. For IEI-EMF individuals SMD ranged from -0.19 to 0.11, all of them with confidence intervals crossing the value of zero. Further, the available evidence suggested that study volunteers could not perceive the EMF exposure status better than what is expected by chance and that IEI-EMF individuals could not determine EMF conditions better than the general population. Limitations of evidence: experimental conditions are substantially different from real-life situations in the duration, frequency, distance and position of the exposure. Most studies were conducted in young, healthy volunteers, who might be more resilient to RF-EMF than the general population. The outcomes of interest in this systematic review were symptoms, which are self-reported. The available information did not allow to assess the potential effects of exposures beyond acute exposure and in elderly or in chronically ill people. It cannot be ruled out that a real EMF effect in IEI-EMF groups is masked by a mix with insensitive subjects. However, studies on symptoms reporting and/or field perceptions did not find any evidence that there were particularly vulnerable individuals in the IEI-EMF group, although in open provocation studies, when volunteers were informed about the presence or absence of EMF exposure, such differences were consistently observed. available evidence suggests that acute RF-EMF below regulatory limits does not cause symptoms and corresponding claims in the everyday life are related to perceived and not to real EMF exposure status.

23 April 2008
Verified
Reference Entry
Closed access
MMMartin Meremikwu
Martin Meremikwu
SDSarah Donegan
Sarah Donegan
EEEkpereonne Esu
Ekpereonne Esu